STOCK TITAN

Vivani (VANI) director adds 1.59M shares in nearly $2M purchase

Filing Impact
(Very High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Vivani Medical, Inc. director and 10% owner Gregg Williams bought 1,587,301 shares of common stock in a private sale at $1.26 per share, under a Share Purchase Agreement dated August 11, 2025. The gross proceeds for this transaction were $1,999,999.26. After the purchase, he beneficially owns a total of 37,743,684 shares, including 4,799,200 shares held directly and additional shares held through several trusts and LLCs over which he has voting and dispositive power.

Positive

  • None.

Negative

  • None.

Insights

Large private share purchase increases Gregg Williams' stake in Vivani Medical.

Gregg Williams, a director and 10% owner of Vivani Medical, Inc., entered a private sale transaction to buy 1,587,301 common shares at $1.26 per share. The gross transaction value was $1,999,999.26, indicating a meaningful capital commitment.

Following this deal, he beneficially owns 37,743,684 shares, combining 4,799,200 directly held shares with positions in multiple trusts and LLCs where he has voting and dispositive power. The filing does not show any concurrent sales, so this appears as a net-buy insider action.

The transaction was executed pursuant to a Share Purchase Agreement dated August 11, 2025, using the prior day’s Nasdaq closing price as the reference. Future company filings may provide additional context on how this increased ownership interacts with governance and strategic decisions.

Insider Williams Gregg
Role Director, 10% Owner
Bought 1,587,301 shs ($2.00M)
Type Security Shares Price Value
Purchase Common Stock 1,587,301 $1.26 $2.00M
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 32,944,484 shares (Indirect, See footnote); Common Stock — 4,799,200 shares (Direct)
Footnotes (1)
  1. The reporting person purchased 1,587,301 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $1,999,999.26. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote. The reporting person owns 37,743,684 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 30,818,732 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.
Shares purchased 1,587,301 shares Common Stock bought in private sale transaction
Purchase price $1.26 per share Price per share in private sale transaction
Transaction value $1,999,999.26 Gross proceeds from private sale transaction
Total beneficial holdings 37,743,684 shares Common Stock owned directly and indirectly after transaction
Direct holdings 4,799,200 shares Common Stock owned directly by Gregg Williams
Gregg G. Williams 2006 Trust holdings 30,818,732 shares Common Stock held by Gregg G. Williams 2006 Trust
Williams International Co. LLC holdings 1,212,856 shares Common Stock held by Williams International Co. LLC
private sale transaction financial
"The reporting person purchased 1,587,301 shares of the Issuer's common stock in a private sale transaction as disclosed..."
Share Purchase Agreement financial
"in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025..."
A share purchase agreement is a written contract that outlines the terms and conditions for buying and selling shares of a company. It specifies details like the price, number of shares, and any special conditions, ensuring both buyer and seller agree on the transaction. For investors, it provides clarity and legal protection, making sure the purchase is clear and enforceable.
voting and dispositive power financial
"and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power..."
generation-skipping trust financial
"and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Williams Gregg

(Last)(First)(Middle)
C/O VIVANI MEDICAL, INC.
1350 S. LOOP ROAD

(Street)
ALAMEDA CALIFORNIA 94502

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/15/2026P(1)1,587,301A$1.2632,944,484ISee footnote(2)
Common Stock4,799,200D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The reporting person purchased 1,587,301 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $1,999,999.26. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.
2. The reporting person owns 37,743,684 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 30,818,732 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.
/s/ Anthony Baldor, Attorney-in-fact04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

How many Vivani Medical (VANI) shares did Gregg Williams buy?

Gregg Williams bought 1,587,301 shares of Vivani Medical common stock. The purchase occurred in a private sale transaction, increasing his overall beneficial ownership and reflecting a net-buy insider action without any reported offsetting share sales in this filing.

What price did Gregg Williams pay per Vivani Medical (VANI) share?

He paid $1.26 per share for the 1,587,301 Vivani Medical shares. This price matched the last reported sale price of Vivani’s common stock on Nasdaq on the trading day immediately before the Share Purchase Agreement date referenced in the filing.

What was the total value of Gregg Williams’ Vivani Medical (VANI) share purchase?

The gross proceeds from the private sale transaction were $1,999,999.26. This figure reflects the aggregate value of 1,587,301 Vivani Medical common shares purchased at $1.26 per share under the disclosed Share Purchase Agreement terms in the filing footnotes.

How many Vivani Medical (VANI) shares does Gregg Williams own after the transaction?

After the transaction, Gregg Williams beneficially owns 37,743,684 Vivani Medical shares. This total includes 4,799,200 shares held directly and additional shares held through several trusts and LLCs, all of which he controls through voting and dispositive power.

How are Gregg Williams’ Vivani Medical (VANI) holdings structured between direct and indirect ownership?

He holds 4,799,200 shares directly, while the remainder are owned through entities including the Gregg G. Williams 2006 Trust, Williams International Co. LLC, Sam Williams Family Investments LLC, and the Sam B. Williams 1995 Generation-Skipping Trust, all under his voting and dispositive control.